Drug discovery

#Artificial intelligence (AI) #Drug discovery #Events #Webinar

Webinar: Hear from the AI and drug discovery experts

Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More

Webinar date:
Sponsored by Benchling
#News

#Appointment #Drug discovery #New appointment

Drug discovery’s senior appointments: Q2 2025

Here, we provide an overview of the c-level moves that have taken place within the industry between April and June 2025. The ABPI has confirmed that Russell Abberley is the latest President-elect. Abberley, Vice President and General Manager of Amgen UK and Ireland, formally took up the Presidency on 13… Read More

#News

Mass spectrometry
#Drug discovery #Lab technology #Mass spectrometry / NMR

Cerno unveils mass spec breakthroughs at ASMS Meeting

Cerno will present new data on its universal mass spectrometry software at the American Society of Mass Spectrometry (ASMS) Annual Meeting in Baltimore MD.   The Cerno team will also demonstrate their MassWorks and GC/ID software and meet with conference attendees at booth #121.  “Across a… Read More

#News

Cancer cells
#Cancer research #Drug discovery #Events #Oncology #Webinar

Webinar: Cancer research developments

This free webinar at 3pm BST on 12 June, hosted by DDW and sponsored by Scale Biosciences, will see experts and thought-leaders from the cancer research sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects in the oncology field. … Read More

Webinar date:
Sponsored by Scale Biosciences
#News

#Drug development #Drug discovery #Obesity #RNA Therapeutics

New DDW Highlights podcast: 2 June 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. News stories of note for this week include a major deal signed between Eli… Read More

#News

#Artificial intelligence (AI) #Drug discovery #Events #Webinar

Webinar: The impact of AI on drug discovery innovation

Hosted by Drug Discovery World and sponsored by Benchling, this free webinar will explore the impact of AI on drug discovery innovation. Taking place on 26 June, the webinar will see AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in… Read More

Webinar date:
Sponsored by Benchling
#News

#Artificial intelligence (AI) #Drug discovery #Events

The impact of AI on drug discovery innovation

Hosted by Drug Discovery World and sponsored by Benchling, this free webinar explores the impact of AI on drug discovery innovation. The webinar sees AI experts and leaders discuss where innovation is occurring and what the challenges are to overcome in drug discovery and development. You will hear from Martin… Read More

Webinar date:
Sponsored by Benchling
#Webinars

Francis Crick Institute
#Drug discovery #Events #Turning Science into Business Symposium

Speakers announced for DDW Symposium

On Tuesday 4 November DDW will be holding its Turning Science into Business Symposium at the Francis Crick Institute in London. Six in-depth topic presentations from industry experts will be followed by a panel discussion examining new processes and technology, with a focus on how they… Read More

#Editor's Choice #News

RNA
#Drug development #Drug discovery #Obesity #RNA Therapeutics

This week in drug discovery (26-30 May)

News round-up for 26-30 May by DDW Editor Reece Armstrong. News stories of note for this week include a major deal signed between Eli Lilly and Rznomics in the field of RNA-editing therapies, and a potential quality-of-life breakthrough for patients with Parkinson’s. Lilly and Rznomics agree $1.3 billion… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Cancer #Drug development #Drug discovery

Insilico Medicine study validates ENPP1 as immune checkpoint for cancers  

Biotechnology company Insilico Medicine has unveiled a new study showcasing how the company’s advanced generative AI platform and integrated workflow helped to identify and validate ENPP1 as a critical immune checkpoint among multiple solid tumours, which helped to the development of a highly specific oral ENPP1 inhibitor, ISM5939. Read More

#News

Biomarkers concept
#Biomarkers #Drug discovery #Endometriosis #Genetics / genomics #Neurodegenerative disorders #Neuroscience #Women's health

New podcast: Innovative uses for biomarkers in drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Innovative uses for biomarkers in drug discovery”, which covers two articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “How biomarkers can help discover new treatments for women’s health” and… Read More

#News

#Drug discovery #SLAS Europe

SLAS Europe round-up 

DDW’s Reece Armstrong looks at the latest announcements that came out of SLAS Europe.   Contract research organisation (CRO) Nanoworx announced its nanomedicine development and optimisation services at this year’s SLAS Europe. The CRO’s new service is designed for academic and industry partners and is tailored to… Read More

#News

#Cancer research #Drug discovery #Events #Oncology #Webinar

Webinar: Innovation and development in cancer research

This free webinar at 3pm BST on 12 June, hosted by DDW and sponsored by Scale Biosciences, will see experts and thought-leaders from the cancer research sector discuss where innovation is occurring and what the challenges are to overcome for drug discovery projects in the oncology field. … Read More

Webinar date:
Sponsored by Scale Biosciences
#News

#Drug discovery #Events #Neuroscience #Webinar

Webinar: Hear from the experts in neuroscience drug discovery

Hosted by Drug Discovery World and sponsored by Emulate, this free webinar explores where innovation is taking place within neuroscience drug discovery.  The webinar sese experts and leaders from the neuroscience sector discuss where innovation is occurring and what the challenges are to overcome for drug… Read More

Webinar date:
Sponsored by Emulate
#News

#Drug discovery

Webinar: Advancing high-throughput cardiac screening with physiologically relevant 3D iPSC-based models

Balancing assay throughput with physiological relevance is essential for improving disease modelling and compound screening in preclinical drug development. Induced pluripotent stem cell (iPSC) technology has revolutionised early drug discovery by integrating human biology, enhancing predictions of drug safety and efficacy. However, achieving both scalability and consistency in high-throughput applications… Read More

#Webinars